Brachial flow-mediated dilation and incident atrial fibrillation the multi-ethnic study of atherosclerosis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 34, Issue 12, 2014, Pages 2717-2720

  O'Neal, Wesley T ^a   Efird, Jimmy T ^a,d   Yeboah, Joseph ^b   Nazarian, Saman ^e   Alonso, Alvaro ^f   Heckbert, Susan R ^g   Soliman, Elsayed Z ^b,c  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b Section on Cardiology   (United States)

^c Epidemiological Cardiology Research Center Epicare   (United States)

^d EAST CAROLINA UNIVERSITY   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

^g UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Atrial fibrillation; Endothelium; Epidemiology

Indexed keywords

ADULT; ARTICLE; BRACHIAL ARTERY; BRACHIAL FLOW MEDIATED DILATION; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICARE; PROPORTIONAL HAZARDS MODEL; AGED; ATHEROSCLEROSIS; ATRIAL FIBRILLATION; BLOOD FLOW VELOCITY; CLINICAL TRIAL; COHORT ANALYSIS; ECHOGRAPHY; ETHNIC GROUP; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM; VASODILATATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; ATRIAL FIBRILLATION; BLOOD FLOW VELOCITY; BRACHIAL ARTERY; COHORT STUDIES; ENDOTHELIUM, VASCULAR; ETHNIC GROUPS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; VASODILATION;

EID: 84918790063     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.114.304560     Document Type: Article

References (21)

1. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111-1115.
2. Neunteufl T, Katzenschlager R, Hassan A, Klaar U, Schwarzacher S, Glogar D, Bauer P, Weidinger F. Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease. Atherosclerosis. 1997;129:111-118.
3. Perrone-Filardi P, Cuocolo A, Brevetti G, Silvestro A, Storto G, Dellegrottaglie S, Corrado L, Cafiero M, Camerino R, Polimeno M, Zarrilli A, Caiazzo G, Maglione A, Petretta A, Chiariello M. Relation of brachial artery flow-mediated vasodilation to significant coronary artery disease in patients with peripheral arterial disease. Am J Cardiol. 2005;96:1337-1341.
4. Yeboah J, Crouse JR, Hsu FC, Burke GL, Herrington DM. Brachial flowmediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study. Circulation. 2007;115:2390-2397.
5. Yeboah J, Folsom AR, Burke GL, Johnson C, Polak JF, Post W, Lima JA, Crouse JR, Herrington DM. Predictive value of brachial flowmediated dilation for incident cardiovascular events in a populationbased study: the multi-ethnic study of atherosclerosis. Circulation. 2009;120:502-509.
6. Freestone B, Chong AY, Nuttall S, Lip GY. Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels. Thromb Res. 2008;122:85-90.
7. Skalidis EI, Zacharis EA, Tsetis DK, Pagonidis K, Chlouverakis G, Yarmenitis S, Hamilos M, Manios EG, Vardas PE. Endothelial cell function during atrial fibrillation and after restoration of sinus rhythm. Am J Cardiol. 2007;99:1258-1262.
8. Kim YM, Guzik TJ, Zhang YH, Zhang MH, Kattach H, Ratnatunga C, Pillai R, Channon KM, Casadei B. A myocardial Nox2 containing NAD(P) H oxidase contributes to oxidative stress in human atrial fibrillation. Circ Res. 2005;97:629-636.
9. Lin YK, Lu YY, Chen YC, Chen YJ, Chen SA. Nitroprusside modulates pulmonary vein arrhythmogenic activity. J Biomed Sci. 2010;17:20.
10. Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, Seward JB, Tsang TS. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006;114:119-125.
11. Endemann DH, Schiffrin EL. Endothelial dysfunction. J Am Soc Nephrol. 2004;15:1983-1992.
12. Haïssaguerre M, Jaïs P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Métayer P, Clémenty J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339:659-666.
13. Aviles RJ, Martin DO, Apperson-Hansen C, Houghtaling PL, Rautaharju P, Kronmal R.A., Tracy RP, Van Wagoner DR, Psaty BM, Lauer MS, Chung MK. Inflammation as a risk factor for atrial fibrillation. Circulation. 2003;108:3006-3010.
14. Celermajer DS, Sorensen KE, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Deanfield JE. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol. 1994;24:471-476.
15. McVeigh GE, Brennan GM, Johnston GD, McDermott BJ, McGrath LT, Henry WR, Andrews JW, Hayes J.R. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1992;35:771-776.
16. Paniagua OA, Bryant MB, Panza JA. Role of endothelial nitric oxide in shear stress-induced vasodilation of human microvasculature: diminished activity in hypertensive and hypercholesterolemic patients. Circulation. 2001;103:1752-1758.
17. Celermajer DS, Sorensen KE, Georgakopoulos D, Bull C, Thomas O, Robinson J, Deanfield JE. Cigarette smoking is associated with dose-related and potentially reversible impairment of endotheliumdependent dilation in healthy young adults. Circulation. 1993;88(5 Pt 1):2149-2155.
18. Weiner SD, Ahmed HN, Jin Z, Cushman M, Herrington DM, Nelson JC, Di Tullio MR, Homma S. Systemic inflammation and brachial artery endothelial function in the Multi-Ethnic Study of Atherosclerosis (MESA). Heart. 2014;100:862-866.
19. Alonso A, Agarwal SK, Soliman EZ, Ambrose M, Chamberlain AM, Prineas RJ, Folsom AR. Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J. 2009;158:111-117.
20. Jensen PN, Johnson K, Floyd J, Heckbert SR, Carnahan R, Dublin S. A systematic review of validated methods for identifying atrial fibrillation using administrative data. Pharmacoepidemiol Drug Saf. 2012;21(suppl 1):141-147.
21. Bengtson LG, Kucharska-Newton A, Wruck LM, Loehr LR, Folsom AR, Chen LY, Rosamond WD, Duval S, Lutsey PL, Stearns SC, Sueta C, Yeh HC, Fox E, Alonso A. Comparable ascertainment of newly-diagnosed atrial fibrillation using active cohort follow-up versus surveillance of centers for medicare and medicaid services in the atherosclerosis risk in communities study. PLoS One. 2014;9:e94321.